Healthcare
Our Healthcare team is recognised as one of the most experienced advisers to healthcare businesses across the mid-market.
Healthcare M&A for the mid-market
The team combines deep sector expertise, extensive buyer and investor relationships, and hands-on execution to deliver exceptional outcomes for founders, shareholders, management teams and private equity investors.
For businesses operating across healthcare services, life sciences, medtech and consumer healthcare markets, growth, investment and exit decisions require more than transactional support. They demand advisers who understand the complex regulatory landscape, evolving patient needs, reimbursement dynamics and the strategic priorities of healthcare investors and acquirers.
Arrowpoint Advisory is a leading Healthcare M&A adviser, providing expert mid-market corporate finance advice across healthcare services, life sciences, medtech, healthcare technology and consumer healthcare markets. We advise founders, shareholders, management teams and investors on acquisitions, disposals, growth capital and strategic transactions that accelerate growth and maximise shareholder value. Our experience spans the full healthcare ecosystem, supporting businesses through complex and highly competitive Healthcare M&A processes.
Our expertise in Healthcare M&A
We have a proven track record advising high-quality businesses across sub-sectors including:
Healthcare Services
Including primary care, specialist healthcare providers, diagnostics, care services, veterinary services and outsourced healthcare businesses, where we advise companies benefiting from growing demand, resilient market fundamentals and attractive demographic tailwinds. We support entrepreneurs and investors through growth capital, acquisitions, succession planning and exit transactions.
Life Sciences
Including clinical research organisations, pharmaceutical services, drug development, laboratory services and specialist scientific businesses, where we advise companies operating at the forefront of medical innovation. Our experience helps shareholders navigate complex Healthcare M&A transactions and identify strategic partners capable of accelerating growth and international expansion.
Medtech & Medical Devices
Including medical device manufacturers, distributors, diagnostic technologies and specialist healthcare equipment providers, where we support businesses delivering innovative products and solutions that improve patient outcomes. We help management teams and investors realise value through acquisitions, fundraising and strategic partnerships.
Healthcare Technology & Digital Health
Including healthcare software, data analytics, patient engagement platforms, healthcare communications and technology-enabled service providers, where we advise businesses benefiting from digital transformation across healthcare systems. Our Healthcare M&A specialists help clients unlock value through strategic sales, acquisitions and investment processes.
Consumer Healthcare & Wellness
Including healthcare brands, preventative health, aesthetics, wellness solutions and consumer-focused healthcare products and services, where we support businesses benefiting from rising consumer awareness, ageing populations and increasing demand for personal health and wellbeing solutions. We advise on transactions that facilitate growth and create long-term shareholder value.
Healthcare Support Services
Including healthcare transport, outsourced clinical services, procurement, supply chain solutions and specialist support providers, where we advise businesses operating critical services across the healthcare ecosystem. Our expertise spans a broad range of Healthcare M&A transactions, supporting growth, investment and exit strategies across the sector.
How we support Healthcare companies
As part of Rothschild & Co, Arrowpoint Advisory is the only mid-market financial adviser delivering detailed sector insight on a global platform. This unique combination of international reach, local market knowledge and specialist sector expertise provides clients with access to buyers, investors and opportunities that are typically only available to larger multinational businesses.
Our Healthcare team has specialist knowledge spanning healthcare services, life sciences, medtech, healthcare technology and consumer healthcare. We have extensive experience advising on domestic and cross-border Healthcare M&A transactions and work closely with founders, management teams and investors as they navigate critical strategic milestones.
Through deep market knowledge, extensive investor relationships and rigorous execution, we help mid-market businesses achieve exceptional outcomes and realise their strategic ambitions.
Our Healthcare transactions
Frequently asked questions
Why work with a specialist Healthcare M&A adviser?
Healthcare businesses operate in highly specialised markets characterised by regulation, technological innovation, demographic change and evolving patient expectations. An adviser with specialist Healthcare M&A expertise understands the key value drivers, buyer landscape and investor appetite across the sector, ensuring shareholders achieve the best possible outcome from a transaction.
What types of Healthcare businesses do you advise?
We advise mid-market businesses across the healthcare ecosystem, including healthcare services, life sciences, medtech, healthcare technology, consumer healthcare and specialist support services. Our team has extensive experience delivering successful Healthcare M&A transactions for founders, corporates, healthcare investors and private equity firms.
How are Healthcare businesses valued?
While valuation methodologies vary by subsector, value is typically driven by factors such as growth profile, recurring revenues, regulatory positioning, clinical outcomes, technology differentiation, intellectual property, management quality and strategic attractiveness to buyers and investors. Every business is unique, and our advice is tailored to maximise value and transaction outcomes.
In particular, businesses operating in attractive healthcare markets often benefit from strong investor demand, resilient end-market fundamentals and exposure to long-term demographic and healthcare trends, all of which can be important drivers of value in Healthcare M&A transactions.
What trends are shaping the Healthcare sector?
The sector continues to experience strong Healthcare M&A activity, driven by ageing populations, increased healthcare spending, technological innovation, digital transformation and growing investor interest in defensive, high-growth healthcare assets. Businesses with differentiated capabilities, scalable platforms and exposure to long-term structural growth trends remain highly attractive to strategic acquirers and financial investors.
Speak to our Healthcare M&A specialists
To find out how we can assist your strategic goals and transaction requirements with absolute discretion, give us a call today on +44 (0) 20 7484 4700, or send an email to contactus@arrowpointadvisory.com.
